Balcoltra FDA Approval History
FDA Approved: Yes (First approved January 9, 2018)
Brand name: Balcoltra
Generic name: ethinyl estradiol/levonorgestrel and ferrous bisglycinate
Dosage form: Tablets
Company: Avion Pharmaceuticals, LLC
Treatment for: Birth Control
Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) is a progestin/estrogen combination oral contraceptive (COC) indicated for use by females of reproductive potential to prevent pregnancy.
Development timeline for Balcoltra
| Date | Article |
|---|---|
| Jan 17, 2018 | Approval Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
